Laser surgery for drug-resistant epilepsy
Part of Brain & nervous system clinical trials.
This trial tests a new, less invasive surgery called MRI-guided laser ablation (MRgLITT) for people with drug-resistant mesial temporal lobe epilepsy. It aims to stop or reduce seizures by using a laser to destroy the tiny area of the brain causing them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have drug-resistant mesial temporal lobe epilepsy (meaning seizures that start in a specific area of the brain and don't respond to medication).
- You have at least one seizure per month.
- You have not had brain surgery before.
- You do not have any other growths or lesions in your brain (like tumors or cysts).
- You do not have serious health problems that would make surgery risky (like severe heart disease, lung problems, or an uncontrolled infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI scans to look more closely at the brain changes in people with temporal lobe epilepsy. The goal is to better understand the condition and possibly improve diagnosis and treatment.
This study tests a new, non-invasive treatment called 'temporal interference' for people whose epilepsy seizures are not controlled by medication. It aims to reduce seizures by using low-level electrical fields to calm overactive brain cells.
This trial tests a new cell-based treatment for people with epilepsy that has not improved with standard medications. The treatment aims to reduce seizures in patients with a specific type of epilepsy originating from one side of the brain.
This trial tests a new, gentle way to stimulate specific brain areas using a special electrical signal. It aims to see if this can help people with epilepsy that hasn't improved with medication.
This trial looks at using brain surgery to treat epilepsy that does not improve with usual medicines, or epilepsy caused by a brain tumor. It may help some people reduce seizures if surgery is appropriate for their situation.
This trial tests a minimally invasive brain surgery that targets a small area deep in the brain to stop seizures in people whose epilepsy has not improved with medications. It may help reduce or eliminate seizures caused by scarring in the temporal lobe.
Hear when a new Temporal Lobe Epilepsy (TLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.